These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A serological study of children vaccinated against measles. Strauss J; Zdrazílek J; Svandová E; Sejda J; Helcl J J Hyg Epidemiol Microbiol Immunol; 1969; 13(4):468-81. PubMed ID: 5391988 [No Abstract] [Full Text] [Related]
27. [Results of a trial of an erythrocyte measles diagnostic agent in public health institutions]. Polzik TP; Kashkina GB; Andrianova DP; Bol'shakova SL; Petrova MA Tr Inst Im Pastera; 1981; 56():112-4. PubMed ID: 6764964 [No Abstract] [Full Text] [Related]
28. [Considerations on the activities of the virological section of the Laboratorio di Analisi and on the clinical diagnosis of viral diseases]. Ferrucci M Arcisp S Anna Ferrara; 1968; 21():Suppl:799-809. PubMed ID: 5732144 [No Abstract] [Full Text] [Related]
29. Durability of antibodies induced by inactivated measles virus vaccine. Masuno S; Kaneko T; Arakawa S Zentralbl Bakteriol Orig; 1968 Apr; 206(3):353-60. PubMed ID: 5707315 [No Abstract] [Full Text] [Related]
30. Viral diagnosis: the patient and the physician. Dmochowski L Am J Clin Pathol; 1972 Jun; 57(6):733-6. PubMed ID: 4554719 [No Abstract] [Full Text] [Related]
31. Evaluation of the measles clinical case definition. Hutchins SS; Papania MJ; Amler R; Maes EF; Grabowsky M; Bromberg K; Glasglow V; Speed T; Bellini WJ; Orenstein WA J Infect Dis; 2004 May; 189 Suppl 1():S153-9. PubMed ID: 15106104 [TBL] [Abstract][Full Text] [Related]
32. Studies on the synthesis of basic proteins and antigenic components in measles virus infected cells. Polna I; Rzendowska F; Beker J; Hirszfeld G; Sadowski W Acta Microbiol Pol; 1980; 29(3):273-84. PubMed ID: 19852113 [TBL] [Abstract][Full Text] [Related]
35. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district. Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640 [No Abstract] [Full Text] [Related]
36. The serologic diagnosis of parasitic disease. Med Lett Drugs Ther; 1971 Feb; 13(4):15-6. PubMed ID: 4998064 [No Abstract] [Full Text] [Related]
37. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE. GARD S; CARLSTROEM G; LAGERCRANTZ R; NORRBY E Arch Gesamte Virusforsch; 1965; 16():315-23. PubMed ID: 14322885 [No Abstract] [Full Text] [Related]
38. The present status of the complement fixation test in viral serodiagnosis. Swack NS; Gahan TF; Hausler WJ Infect Agents Dis; 1992 Aug; 1(4):219-24. PubMed ID: 1365549 [TBL] [Abstract][Full Text] [Related]
39. [Comparison between the plaque reduction neutralization test and the hemagglutination inhibition test in determination of human anti-measles antibodies]. Kong J; Guo SH; Ze WY Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):105-7. PubMed ID: 8758407 [TBL] [Abstract][Full Text] [Related]
40. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine. Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]